FDA Circular No. ____ Subject: Guidelines on the Classification of Deficiencies Observed During Inspection of the Conduct of Clinical Trials; (4 page(s), in English)

Draft partial amendment of the Enforcement Decree of the Act on Registration and Evaluation of Chemical Substances; (23 page(s), in Korean)

The Cosmetic Products (Restriction of Chemical Substances) Regulations 2025.; (2 page(s), in English)